(Q39998437)

16 September 2017

title

TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells (English)

1 reference

16 September 2017

Emi E Nakayama

1

1 reference

16 September 2017

Yasuhiro Shingai

series ordinal

2

1 reference

16 September 2017

Ken Kono

series ordinal

3

1 reference

16 September 2017

Tatsuo Shioda

series ordinal

4

1 reference

16 September 2017

language of work or name

English

0 references

publication date

25 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

375

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

514-520

1 reference

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

16 September 2017

cites work

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Specific incorporation of cyclophilin A into HIV-1 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

The ability of multimerized cyclophilin A to restrict retrovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Effect of cyclophilin A on gene expression in human pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Retroviral restriction factor TRIM5alpha is a trimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

A CCR2-V64I polymorphism affects stability of CCR2A isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

The tripartite motif family identifies cell compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Functional association of cyclophilin A with HIV-1 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

The control of viral infection by tripartite motif proteins and cyclophilin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Trim5alpha protein restricts both HIV-1 and murine leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.02.028

1 reference

16 September 2017

1 reference